Background The introduction of new technology has increased the hospital cost of THA. Considering the impending epidemic of hip osteoarthritis in the United States, the projections of THA prevalence, and national costcontainment initiatives, we are concerned about the decreasing economic feasibility of hospitals providing THA. Questions/purposes We compared the hospital cost, reimbursement, and profit/loss of THA over the 1990 to 2008 time period. Methods We reviewed the hospital accounting records of 104 patients in 1990 and 269 patients in 2008 who underwent a unilateral primary THA. Hospital revenue, hospital expenses, and hospital profit (loss) for THA were evaluated and compared in 1990, 1995, and 2008. 
Introduction
The prevalence of THA in the United States increased each year between 1990 and 2008, and demand for primary THA is projected to grow to 572,000 procedures by 2030 [9] . However, although demand for THA increased, Medicare hospital payment for primary THA increased only 29% (actual dollars; $8500 in 1990 and $11,080 in 2008) [13] . During this 18-year time interval, the rate of inflation was 58%, or double the increase in reimbursement [17] . In the 1990s, hospital expenses were controlled through utilization review, decreased length of stay, and implant cost reduction programs [6] [7] [8] . Increased labor costs and the cost of technology introduction in the new millennium threaten to offset the control of hospital expenses achieved in the 1990 s. The decreased relative revenue, coupled with rising hospital expenses for THA, presents a serious challenge for a hospital and its ability to break even or profit on THA.
The use of alternative bearing surfaces such as highly crosslinked polyethylene, highly polished metals, and ceramics has increased considerably over the past decade, especially in the younger, more active patient population. These materials may offer clinical advantages, but they are expensive, and alternative bearing surfaces contribute to rising costs for THA. Advocates for these bearing surfaces state they offer the potential for reduced implant failures secondary to decreased bearing surface wear [16] . However, evidence of improved long-term clinical outcomes in terms of superior implant survival has not yet been demonstrated [5] .
We compared the hospital economics of primary THA at Lahey Clinic from 1990 to 2008. The differences in reimbursement by health insurance payers were analyzed. Hospital expenses were analyzed to determine if the cost associated with hospital service centers had changed from 1990 to 2008. Finally, we determined whether the use of alternative bearing surfaces alter a hospital's ability to profit or break even for THA.
Patients and Methods
We reviewed the hospital accounting records of 104 patients in 1990 and 269 patients in 2008 who underwent a unilateral primary THA. In 2008, 282 patients underwent primary THA at Lahey Clinic. Patients who had femoral head resurfacing, bilateral THA, revision THA, complications related to THA, and a secondary operative procedure during the same hospitalization were excluded from the study. Patients for whom there were insufficient billing data were excluded (Table 1) . For 2008, we excluded 13 patients because they were part of the Centers for Medicare and Medicaid Services' (CMS) Diagnosis Related Group (DRG) MS-DRG 469 (major joint replacement of lower extremity with major comorbidities). This group has a reimbursement for THA different from that of MS-DRG 470 (major joint replacement of lower extremity without major comorbidities) ( Table 1 ). The exclusions left 269 patients for 2008.
The average age of the 104 study patients in 1990 was 68 years (range, 53-87 years). The primary diagnosis was osteoarthritis for 85 patients (82%), rheumatoid arthritis for three patients (3%), osteonecrosis for five patients (5%), and other for 11 patients (10%). The average age of the 269 study patients in 2008 was 69 years (range, 18-93 years). The primary diagnosis was osteoarthritis for 237 patients (88%), rheumatoid arthritis for seven patients (2%), osteonecrosis for 12 patients (5%), and other for 13 patients (5%) ( Table 1) .
All patients had a primary THA at Lahey Clinic. Two surgeons performed the operations in 1990, and six surgeons (including the previous two surgeons) performed the operations in 2008. From 1995 to the present, the management of all patients undergoing THA was standardized according to a clinical pathway [6] [7] [8] . All procedures involved arthroplasty of both the acetabulum and femur. The average hospital stay was 9.3 days in 1990 and 4.1 days in 2008 (Table 1) .
Hospital revenue, hospital expenses, and hospital profit (loss) for THA were evaluated and compared in 1990, 1995, and 2008. To compare data from 1990 and 1995 with data from 2008, 1990, and 1995, US dollars were converted to inflation-adjusted 2008 US dollars with the consumer price index for all urban consumers obtained from the Bureau of Labor Statistics [16] . In 1990 and 1995, hospital revenue for THA for all 104 patients was provided through the Medicare DRG system administered by the Health Care Financing Administration (DRG-209; major joint replacement of lower extremity). In 2008, hospital revenue for THA for these 269 patients is reported in four payer categories: Medicare fee-for-service (FFS) (115), managed Medicare (38), major private health plans (76), and other payers (40). Hospital payment for Medicare FFS patients was provided through the Medicare MS-DRG system administered by CMS (MS-DRG 470; major joint replacement of lower extremity without major comorbidities).
Hospital expenses for THA were determined by different methods in 1990, 1995, and 2008. In 1990, hospital cost data were established using government-mandated, hospitalspecific, cost-to-charge ratios. This method of determining hospital cost was generally accepted in 1990. In 1995 and 2008, a resource-based hospital accounting system (TSI Inc, Cambridge, MA) provided actual hospital cost data for each procedure. The 17 service center breakdown was not available for the 1995 cohort. Direct and indirect costs were assigned to hospital services based on cost data within the system.
In 1990, hospital expenses were allocated to six service centers. The major areas of comparison were the operating room, the hospital room, and supplies. Hospital expenses were allocated to 17 service centers in 2008 such as the laboratory, operating room (OR), or radiology department, for which charges and costs are available. The anesthesiology service center included operative anesthetics and the technical costs used for each case. The blood bank service center included blood type tests and transfusion costs. The electrocardiology service center included perioperative electrocardiograms. The hospital room service center included all hospital floor-related costs during a patient's stay from nursing to meals to dressing change supplies. Intravenous therapy included intravenous and peripherally inserted central catheter placement costs. Daily phlebotomy draws and laboratory work such as complete blood count, international normalized ratio, and basic metabolic profile were included in the laboratory service center. The OR service center included staff and administrative expenses. The orthopaedic appliance service center included abduction pillows. Pathology included pathologic evaluation of OR specimens. The pharmacy service center included perioperative medications such as antibiotics, analgesics, anticoagulants, etc, administered during a patient's hospital course. The initial physical therapy/ occupational therapy (PT/OT) evaluation and daily gait training and therapeutic activities were all included in the PT/OT service center. Perioperative chest radiographs and postoperative hip radiographs were among the costs included in the radiology service center. The recovery room cost included staff and administrative expenses. Postoperative ventilatory support, continuous positive airway pressure, and pulse oximetry were included in the respiratory therapy service center. Supplies (medical and operative) included specific products with variable cost purchased by the hospital for THA. The cost of hip implants was included in this service center. Specific implant prices are not provided as a result of purchasing agreements with implant manufacturers. Noninvasive scans of the lower extremity to evaluate for thromboembolic disease accounted for the vascular laboratory service center. The other service center included miscellaneous services/testing performed postoperatively (Tables 2, 3) .
Results
In 1990 [6] , which minimized the impact of new technology on the cost of implants and preserved the hospital profits in this non-Medicare subgroup ( Table 4) .
When hospital expenses were allocated to the 17 service centers, the hospital room, OR, and supplies (medical and operative) service centers represented the largest percentage of hospital expense. These three service centers accounted for 77.6% of hospital cost in 1990 and 72.8% in 2008. The hospital room service center accounted for $4541 (36.8%) in 1990 and $3739 (32.0%) in 2008, a decrease of 5% in actual dollars (Tables 2, 3 ). The reduction in cost for the hospital room service center was associated with the reduction in length of stay. The OR service center for THA accounted for $2099 (17.0%) in 1990 and $2267 (19.4%) in 2008, an increase of 2.4% in actual dollars (Tables 2, 3, 5).The supplies (medical and operative) service center for THA accounted for $2947 (23.9%) in 1990 and $2506 (21.4%) in 2008, a decrease of 2.4% in actual dollars. The reduction in cost for the supplies service center was associated with reduction of hip implant cost (Tables 2-4 ).
Our economic results for THA for 38 managed Medicare patients presented an unfavorable comparison with our Medicare FFS patients. Hospital revenue per case was 19% less ($11,405 versus $14,003); hospital expense per case was similar ($10,755 versus $11,674); and hospital 
Discussion
Hospital reimbursement for THA has lagged behind inflation, and expenses have increased primarily as a result of increased labor costs and increased implant costs. This trend is concerning; given the increasing prevalence of THA, which is projected to grow to 572,000 procedures by 2030 [10] . It has been reported that some hospitals cannot make a profit when delivering medical and surgical services with current Medicare payment schedules [9, 15] . We evaluated and compared the hospital economics of primary THA at Lahey Clinic in 1990, 1995, and 2008. In addition, we reviewed the use of alternative bearing surfaces and how their use alters a hospital's ability to profit or break even for THA. Our study is subject to certain limitations. First, our sample size was small in 1990 and was limited to the Medicare DRG cohort. The 1995 cohort also was limited to FFS = fee for service; IME = indirect medical education. the Medicare DRG group. In the 2008 patient group, all insurers are reported and it has been broken out so that appropriate comparisons can be made with the prior patient groups. Second, the resource-based accounting system, which was used for the 2008 cohort service center breakdown, was not available in 1990 and was not archived for the 1995 cohort. The major service centers of comparison, however, OR, patient room, and supplies (surgical and medical), were supplied for the 2008 and 1990 cohorts. Third, patients in the MS-DRG 469 (major joint replacement of lower extremity with major comorbidity) were eliminated from this study to standardize the comparison with the cohort from 1990 where outliers had also been eliminated. Fourth, a strength and weakness of this study was that all operations were performed in one hospital, by one group of surgeons within one group practice, using a standardized clinical pathway and all implants were purchased from one vendor in each year studied. All surgeons were salaried employees of Lahey Clinic and had an interest in preserving the economic health of their hospital. This is a distinct difference from private hospitals where surgeons are not salaried members of the staff and have less incentive to work with their hospitals to control the hospital cost of THA. The major strength of this study is the quality of the data from the Lahey Clinic Finance Department. The resource-based accounting system reported actual cost data for 17 service centers and enabled us to report where the expenses had increased and decreased over an 18-year examination of hospital costs.
In response to the losses on THA operation in 1990, orthopaedic surgeons and administrators at Lahey Clinic [6] [7] [8] (Table 4 ). Managed Medicare hospital profit for primary THA was 84% less per case. In a healthcare environment with increasing demand for THA, decreasing hospital reimbursement, and increasing labor and supply expenses, this current dynamic is unsustainable.
Evaluations of hospital economics for THA should include a discussion of alternative joint bearing surfaces. Several studies have suggested alternative bearing surfaces reduce wear rates [1, 3, 4] . However, there are no studies demonstrating the long-term clinical benefits from these bearing surfaces [5] . Bozic et al. [2] evaluated the theoretical benefits of alternative bearing surfaces and found the cost-effectiveness of their use is highly dependent on the age of the patient at the time of surgery, the cost of the implant, and the associated reduction in the probability of revision relative to conventional bearing surfaces. Prior studies have examined the cost-effectiveness of new technologies for use in THA. Vale et al. [18] used clinical effectiveness data and cost data to estimate the costeffectiveness of metal-on-metal resurfacing for treating patients 65 years and older. The authors concluded metalon-metal resurfacing could be cost-effective versus conventional THA if revision rates were 20% lower.
In 2008, the market share of alternative bearings was 27% with metal-on-metal accounting for 24% of the market and ceramic-on-ceramic accounting for 3% of the market [13] . For 2008, if the average selling price of a ceramic-on-ceramic hip implant of $7754 was substituted for all patients, Lahey Clinic would have lost $1147 per patient [13, 14] . For Medicare FFS patients, Lahey Clinic would have lost $1971 and for managed Medicare patients, Lahey Clinic would have lost $4599. If the 2008 average selling price of a metal-on-metal hip implant of $7141 was substituted for all patients, Lahey Clinic would have lost $534 per patient.
To better understand the trend of hospital economic results for THA, we examined our revenue, expense, and profit (loss) at six time points from 1990 to 2008. All the information is from our hospital [7, 8, 11, 12] (Fig. 1) . In inflation-adjusted dollars, comparing Medicare FFS patients, hospital profit increased from 1990 to 1996 and then decreased from 1996 to 2008. In inflation-adjusted dollars, hospital expense for THA decreased from 1990 to 2008. Hospital cost has been actively managed since the early 1990s and facilitated the increase in profit between 1990 and 1995. However, despite effective cost control strategies, our hospital profit for THA peaked with hospital revenue in 1996, and profit decreased from 1996 to 2008 in inflation-adjusted dollars.
If hospital revenue for THA decreases to managed Medicare levels, it will be difficult to make a profit on THA. To maintain access for our patients, hospitals and surgeons should collaborate to deliver THA at a profit so it will be available to all patients with painful arthritic hips. Government healthcare administrators and health insurance payers should provide adequate reimbursement for hospitals and surgeons to continue the delivery of high-quality THAs.
